Stephane Bancel bought $5.0M of MRNA
Chief Executive Officer at Moderna, Inc.. 160,314 shares at an average of $31.22, traded Mar 3, 2025, filed Mar 4, 2025.
Score components
- +25RoleCEO
- +25Trade size$5.0M at market
- 0Relative to holdingsHoldings up 1.8%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001127602-25-007916, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 3, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +102,821 | $31.04 | $3.2M | 9,153,193 | Mar 4, 2025 |
| Mar 3, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +57,493 | $31.53 | $1.8M | 9,210,686 | Mar 4, 2025 |
Related signals
Other insiders at Moderna, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | Moderna, Inc. | Stephen Hoge President | $12M 80,575 shares | -5% | |
| 37Weak | Moderna, Inc. | James M Mock Chief Financial Officer | $4.7M 34,836 shares | -37% | |
| 13Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $486k 3,471 shares | -4% | |
| 0Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $24k 529 shares | -3% | |
| 0Weak | Moderna, Inc. | Stephen Hoge President | $14k 314 shares | -0% | |
| 0Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $4,849 112 shares | -1% | |
| 0Weak | Moderna, Inc. | Stephen Hoge President | $12k 291 shares | -0% | |
| 2Weak | Moderna, Inc. | Shannon Thyme Klinger Chief Legal Officer | $61k 1,418 shares | -7% | |
| 14Weak | Moderna, Inc. | James M Mock Chief Financial Officer | $61k 1,420 shares | -11% | |
| 0Weak | Moderna, Inc. | Stephen Hoge President | $13k 277 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.